Literature DB >> 6135040

Antihistamines and sedation.

A N Nicholson.   

Abstract

With careful use of antihistamines central effects may be minimised or even largely avoided while adequate peripheral antihistaminic activity is preserved. Tolerance to central effects may develop quickly with some drugs, so that sedation is no longer troublesome after a few days. With sustained-release antihistamines, early-evening dosage may provide sufficient activity, without sedation, the next day. For patients in whom daytime sedation is troublesome three drugs, astemizole, mequitazine, and terfenadine, are likely to prove useful. However, the response of the individual patient cannot be predicted, and the possibility of sedation can never be completely excluded.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135040     DOI: 10.1016/s0140-6736(83)90185-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

1.  Clozapine-induced locomotor suppression is mediated by 5-HT2A receptors in the forebrain.

Authors:  Caitlin E McOmish; Alena Lira; James B Hanks; Jay A Gingrich
Journal:  Neuropsychopharmacology       Date:  2012-08-08       Impact factor: 7.853

2.  Antihistamines: impaired performance and the tendency to sleep.

Authors:  A N Nicholson; B M Stone
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  A pharmacologic study on the histamine releasing effect of atracurium and other muscle relaxants in rat isolated ileum.

Authors:  F A Wali; A H Suer; E McAteer; A Hayter; A C Tugwell; V Makinde
Journal:  Agents Actions       Date:  1987-10

4.  Biphasic effects of intra-accumbens histamine administration on spontaneous motor activity in the rat; a role for central histamine receptors.

Authors:  L J Bristow; G W Bennett
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

5.  Comparison of the central and peripheral effects of cetirizine and terfenadine.

Authors:  J C Pechadre; D Vernay; J F Trolese; M Bloom; P Dupont; J P Rihoux
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Newer non-sedating antihistamines. Will they replace older agents?

Authors:  M L Brandon
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546

7.  Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse.

Authors:  Kazumi Takahashi; Jian-Sheng Lin; Kazuya Sakai
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

8.  Antihistaminic/antiallergic activity of 2-dialkylaminoalkylthio(oxy)-1-substituted benzimidazoles: evaluation "in vitro" and "in vivo".

Authors:  S Dini; G F Caselli; C Basilico; A Lavezzo; R Giani
Journal:  Agents Actions       Date:  1990-04

9.  Induction of prolonged, continuous slow-wave sleep by blocking cerebral H₁ histamine receptors in rats.

Authors:  Masami Ikeda-Sagara; Tomoya Ozaki; Mohammad Shahid; Eri Morioka; Kazuma Wada; Kazuki Honda; Ayana Hori; Yuji Matsuya; Naoki Toyooka; Masayuki Ikeda
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

10.  Characterization and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in primary antiphospholipid syndrome (APS).

Authors:  M B Hill; J L Phipps; R G Malia; M Greaves; P Hughes
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.